Gavreto Liên Minh Châu Âu - Tiếng Ba Lan - EMA (European Medicines Agency)

gavreto

roche registration gmbh  - pralsetinib - rak, niedrobnokomórkowe płuca - Środki przeciwnowotworowe - gavreto is indicated as monotherapy for the treatment of adult patients with rearranged during transfection (ret) fusion-positive advanced non-small cell lung cancer (nsclc) not previously treated with a ret inhibitor.

Camzyos Liên Minh Châu Âu - Tiếng Ba Lan - EMA (European Medicines Agency)

camzyos

bristol-myers squibb pharma eeig - mavacamten - cardiomyopathy, hypertrophic - inne preparaty nasercowe - treatment of symptomatic obstructive hypertrophic cardiomyopathy.